Charleroi, Belgium · Founded 2021 · Privately Held (backing)
Developer of antibiotics designed to fight multiple resistant pathogens. Santero Therapeutics is based in Charleroi, Belgium and was founded in 2021. Its last reported valuation was $13.3 million in Mar 2025. It has raised $9.9 million.
Last reported valuation
$13.3M
Oct 2026
Priced at
—
Total raised
$9.9M
Last round
—
Cap table — not yet on record
Santero Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Santero Therapeutics with a free account
·Watch Santero Therapeutics: the Monday email on marks, rounds and moves
